One hundred twenty male SpragueDawley rats, averaging 108.6 g initial body weight, were used in two feeding experiments to evaluate the utilization of Cu in Cu proteinate, Cu lysine, and cupric sulfate. In Exp.
Introduction
Copper availability may be significantly reduced by some antagonistic elements in the diet, including Zn and Fe (Abdel-Mageed and Oehme, 1991) . To overcome these adverse effects on Cu availability, Cu supplementation is often needed. Providing Cu in a readily available form that is not markedly influenced by Cu antagonists would be a logical approach to overcome these problems. Studies have shown that absorption rate of Cu in the form of Cu-amino acid complexes was higher than that in the inorganic forms for rats (Kirchgessner and Grassmann, 1970a,b; Grassmann and Kirchgessner, 1974) and cattle (Kincaid et al., 1986) . However, other studies indicated that Cu complexes were no more effective than CuSO 4 in improving Cu status of chicks (Baker et al., 1991; Aoyagi and Baker, 1993) or cattle (Wittenberg et al., 1990; Ward et al., 1993) . Very little information is available comparing the utilization of Cu complexes with that of CuSO 4 in the presence of high levels of dietary Zn or Fe. Therefore, the objective of the present study was to determine whether Cu proteinate or Cu lysine can improve the Cu utilization for rats compared with cupric sulfate under normal or high dietary Zn or Fe supplementation.
Materials and Methods

Animals and Experimental Design
Experiment 1. Sixty male Sprague-Dawley rats with an average initial BW of 104.2 g and an initial age of 24 d were randomly assigned to one of 12 treatments in a 2 × 2 × 3 factorial arrangement of treatments. The purified basal diet (Purina, Richmond, IN) contained .81 mg Cu, 20 mg Zn, and 60 mg Fe/kg diet ( Table 1) . The treatments were basal diet supplemented with Zn (ZnCl 2 , Sigma Chemical, St. Louis, MO) at 0 or 1,000 mg/kg diet, Cu at 5 or 15 mg/kg diet, and Cu supplied as cupric sulfate (CuSO 4 ·5H 2 O, Sigma Chemical), Cu proteinate (Bioplex Copper, Alltech, Nicholasville, The rats were individually penned in stainless steel, wire-bottomed cages and fed once a day, with free-choice distilled water available. To adapt to the environment and diet, the rats were fed the basal diet for 7 d before the experiment. The experimental period was 50 d. On d 33, one of the experimental rats died for an unknown reason.
Experiment 2. The basal diet was the same as Exp.
1, and the treatments were similar to those in Exp. 1 except Zn was replaced by Fe (FeSO 4 ·7H 2 O, Sigma Chemical). The average initial BW and age of rats were 112.9 g and 31 d, respectively, and the experimental period was 56 d.
Sampling Procedures and Analytical Methods
Rats were killed at the end of each experiment. Livers, spleens, kidneys, hearts, and lungs of rats were excised and stored at −20°C. The organ samples were dried at 100°C for 36 h and digested using a modified wet-ashing procedure, with two cycles of concentrated nitric acid and one cycle of hydrogen peroxide (30%). Ash was reconstituted in 4 mL of 1 N HCl solution and analyzed for Cu and Zn (Exp. 1 ) or Cu and Fe (Exp. 2 ) via atomic absorption spectrophotometry. Further dilutions were made with 1 N HCl solution as necessary for the analysis.
Statistical Analysis
Data were analyzed using the general linear models ( GLM) procedure of SAS (1990) for a 2 × 2 × 3 factorial arrangement of treatments with a completely randomized design. The model included Zn (or Fe) supplemental level, Cu supplemental level, Cu form, and all interactions. Differences among the Cu forms were determined using the least significant difference ( LSD) test (SAS, 1990) . Significance was declared at P < .05 level.
Results and Discussion
Feed Intake and Body Weight Gain. In Exp. 1, rats supplemented with Cu proteinate or Cu lysine consumed more ( P < .05) feed than rats supplemented with CuSO 4 (Tables 2 and 3 ). There was a significant interaction ( P < .05) in feed intake between Cu supplemental level and Cu form. Copper proteinate increased feed intake more than Cu lysine at 5 ppm supplemental Cu level, whereas at 15 ppm Cu supplementation, feed intake was highest for rats fed Cu lysine. The feed intakes (averaged across supplemental Zn level) were 15.06, 15.84 and 15.32 g/d for rats consuming CuSO 4 , Cu proteinate and Cu lysine with 5 mg Cu/kg feed supplementation; at 15 mg Cu/kg feed supplementation, feed intakes were 15.59, 15.64 and 16.16 g/d, respectively.
At both levels of dietary Zn, rats supplemented with 15 mg Cu/kg diet had higher ( P < .05) feed intakes and body weight gains than rats supplemented with 5 mg Cu/kg (Table 3) ; the latter is the NRC recommendation level. In Exp. 2, dietary treatments had no effect ( P > .05) on feed intake and body weight gain (Tables 4 and 5 ). This does not agree with the result of Exp. 1. No explanation had been deduced.
Copper Concentrations of Organs. Rats fed Cu proteinate had higher ( P < .05) concentrations of Cu in the liver and spleen than rats fed CuSO 4 (Table 3) . The rats fed Cu lysine deposited more ( P < .05) Cu in the spleen and heart than the rats fed CuSO 4 in Exp. 1 (Table 3) .
In Exp. 2, supplementation with Cu proteinate and Cu lysine increased ( P < .05) spleen Cu content more than CuSO 4 (Table 5 ). Overall, liver Cu content was increased by supplementation with Cu proteinate and Cu lysine, but the increase was significant only for Cu lysine ( P < .05, Table 5 ). A significant interaction ( P < .05) between Cu source and dietary Fe level was detected (Table 4) . Copper proteinate increased liver Cu content more than Cu lysine (12.2 vs 11.8 mg/g) at 0 Fe supplementation, whereas Cu lysine increased liver Cu more than Cu proteinate (13.0 vs 12.4 mg/g) at 1,000 mg Fe/kg feed supplementation.
The results from these two experiments indicate that the utilizations of Cu in Cu proteinate and Cu lysine were higher than that of CuSO 4 for rats in the presence or absence of high dietary Zn or Fe (Tables 3  and 5 ). This was consistent with the previous report that Cu-amino acid complexes had a higher availability than CuSO 4 for rats (Kirchgessner and Grassmann, 1970a ). However, the previous studies did not consider the benefits of Cu complexes to nonruminant animals in the presence of dietary Cu antagonistic elements, which are important in animal industry. The Cu proteinate used in the present studies is a mixture of peptide and amino acid-Cu complexes and could be absorbed by several pathways, which could have more benefit to animals than the single peptide or amino acid complexes. Amino acid ligands have a specific effect on Cu absorption rate. Essential amino acid ligands have a high absorption rate, and Cu leucine had the highest absorption and liver Cu storage rate (Kirchgessner and Grassmann, 1970a) . However, other researchers found no significant differences ( P > .05) between Cu complexes and CuSO 4 for chicks and cattle (Baker et al., 1991; Aoyagi and Baker, 1993; Clark et al., 1993) . In Exp. 2, supplementation of Fe increased ( P < .05) Cu deposition in liver and spleen at both levels of dietary Cu (Table 5) . These results were not in agreement with the general concept that high dietary Fe reduces liver Cu content (Storey and Greger, 1987) . Yu (1993) also found that high dietary Fe did not decrease Cu utilization in rats. The kidney Cu content was lowered by high dietary Fe supplementation ( P < .05). A decreased kidney Cu via high dietary Fe was also observed in the studies of Storey and Greger (1987) .
Supplementing with 1,000 mg Zn/kg feed decreased Cu deposition in spleen and heart at the 5 mg Cu/kg diet supplemental level ( P < .05) but not at 15 mg supplemental Cu level ( P > .05, Table 3 ). This response indicated that high dietary Zn decreased utilization of Cu and this antagonist effect was overcome by high dietary Cu. Yu (1993) reported that high dietary Zn did not decrease liver Cu content if Cu was supplemented at or above the requirement level.
High dietary Cu increased ( P < .05) the Cu content of heart compared with normal dietary Cu in Exp. 1 (Tables 2 and 3 ) and of liver, spleen, and heart in Exp. 2 (Tables 4 and 5 ). In Exp. 1, high dietary Cu increased spleen and kidney Cu content at the Zn supplemental level of 1,000 mg/kg feed ( P < .05) but not at the low Zn level (Table 3) . The significant differences ( P < .05, Tables 2 and 3 ) of spleen Cu content among the treatment groups Zinc and Iron Concentrations of Organs. The Cu proteinate treatment groups had higher ( P < .05) liver Zn than the CuSO 4 treatment groups, whereas Cu proteinate treatment groups had lower ( P < .05) lung Zn than CuSO 4 groups. Zinc levels in spleen, heart, and kidney were not affected by the Cu sources in Exp. 1 (Table 3 ). In Exp. 2, the rats supplemented with Cu lysine had higher liver Fe content than the rats supplemented with CuSO 4 ( P < .05), and the rats supplemented with Cu proteinate had higher kidney Fe than the rats supplemented with CuSO 4 ( P < .05, Table 5 ). Copper sources did not influence the Fe content in spleen, heart, or lung. The mechanism for higher utilization of Cu complexes compared with CuSO 4 remains unknown. A higher ( P < .05) liver Zn in the Cu proteinate treatment groups in Exp. 1 (Table 3 ) and higher ( P < .05) liver and kidney Fe in the Cu proteinate and Cu lysine treatment groups in Exp. 2 (Table 5 ) suggest that Cu complexes might be absorbed via another mechanism, which differs from inorganic Cu and does not interfere with Zn and Fe. This is in agreement with the earlier conclusion that metal complexes were absorbed in a dipeptide-like amino acid complex form (Ashmead et al., 1985; Kirchgessner and Grassmann, 1970a) . Mills (1956a,b) concluded that Cu may be transported through the intestinal mucosa both as ionic Cu (inorganic Cu) and in the form of intact complexes. This conclusion was supported by an in vitro study (Ashmead et al., 1985) in which uptake of Cu complexes by rat intestinal segments was three times greater than uptake of CuSO 4 .
As expected, the Zn content of liver, heart, and kidney was significantly increased ( P < .05) by high dietary Zn (Table 3) . The dietary Cu level did not affect ( P > .05) the Zn content in organs because the range of dietary Cu levels was small compared with the range of Zn.
High dietary Fe increased ( P < .05) Fe deposition in liver, spleen, and kidney (Table 5 ). Iron content of heart was 5.2% higher ( P < .05) for the 15 mg Cu/kg feed supplementation groups than for the 5 mg groups.
Implications
The utilization of copper from copper proteinate and copper lysine is higher than that of cupric sulfate when fed to rats both in the presence and absence of supplemental Zn or Fe. Copper complexes increased the Fe content of liver and kidney and decreased the Cu content of kidney compared with cupric sulfate, suggesting different absorption and excretion mechanisms for copper complexes that do not interfere with iron. In addition, liver zinc concentration was higher for the rats fed copper proteinate diet rather than cupric sulfate. Furthermore, spleen and liver copper concentrations may be equivalent as indicators of copper status and utilization of copper for rats.
